South Korea · Delayed Price · Currency is KRW BIO-FD&C Statistics
Total Valuation
BIO-FD&C has a market cap or net worth of KRW 78.26 billion. The enterprise value is 23.01 billion.
| Market Cap | 78.26B |
| Enterprise Value | 23.01B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BIO-FD&C has 8.70 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 8.70M |
| Shares Outstanding | 8.70M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 31.16% |
| Owned by Institutions (%) | 0.07% |
| Float | 5.19M |
Valuation Ratios
The trailing PE ratio is 12.00.
| PE Ratio | 12.00 |
| Forward PE | n/a |
| PS Ratio | 4.01 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | 13.64 |
| P/OCF Ratio | 12.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.06, with an EV/FCF ratio of 4.01.
| EV / Earnings | 3.59 |
| EV / Sales | 1.18 |
| EV / EBITDA | 3.06 |
| EV / EBIT | 3.77 |
| EV / FCF | 4.01 |
Financial Position
The company has a current ratio of 19.09, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.09 |
| Quick Ratio | 17.97 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.03 |
| Interest Coverage | 300.83 |
Financial Efficiency
Return on equity (ROE) is 9.19% and return on invested capital (ROIC) is 28.05%.
| Return on Equity (ROE) | 9.19% |
| Return on Assets (ROA) | 5.23% |
| Return on Invested Capital (ROIC) | 28.05% |
| Return on Capital Employed (ROCE) | 8.34% |
| Weighted Average Cost of Capital (WACC) | 6.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.27 |
| Inventory Turnover | 2.96 |
Taxes
In the past 12 months, BIO-FD&C has paid 1.50 billion in taxes.
| Income Tax | 1.50B |
| Effective Tax Rate | 18.98% |
Stock Price Statistics
The stock price has decreased by -51.64% in the last 52 weeks. The beta is 0.38, so BIO-FD&C's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -51.64% |
| 50-Day Moving Average | 8,421.80 |
| 200-Day Moving Average | 12,671.05 |
| Relative Strength Index (RSI) | 55.79 |
| Average Volume (20 Days) | 14,763 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIO-FD&C had revenue of KRW 19.53 billion and earned 6.41 billion in profits. Earnings per share was 750.04.
| Revenue | 19.53B |
| Gross Profit | 12.95B |
| Operating Income | 6.10B |
| Pretax Income | 7.91B |
| Net Income | 6.41B |
| EBITDA | 7.51B |
| EBIT | 6.10B |
| Earnings Per Share (EPS) | 750.04 |
Balance Sheet
The company has 55.44 billion in cash and 187.52 million in debt, with a net cash position of 55.25 billion or 6,353.81 per share.
| Cash & Cash Equivalents | 55.44B |
| Total Debt | 187.52M |
| Net Cash | 55.25B |
| Net Cash Per Share | 6,353.81 |
| Equity (Book Value) | 72.93B |
| Book Value Per Share | 8,552.24 |
| Working Capital | 58.25B |
Cash Flow
In the last 12 months, operating cash flow was 6.44 billion and capital expenditures -698.32 million, giving a free cash flow of 5.74 billion.
| Operating Cash Flow | 6.44B |
| Capital Expenditures | -698.32M |
| Depreciation & Amortization | 1.41B |
| Net Borrowing | -218.87M |
| Free Cash Flow | 5.74B |
| FCF Per Share | 659.91 |
Margins
Gross margin is 66.29%, with operating and profit margins of 31.22% and 32.80%.
| Gross Margin | 66.29% |
| Operating Margin | 31.22% |
| Pretax Margin | 40.48% |
| Profit Margin | 32.80% |
| EBITDA Margin | 38.45% |
| EBIT Margin | 31.22% |
| FCF Margin | 29.38% |
Dividends & Yields
BIO-FD&C does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.25% |
| Shareholder Yield | -0.25% |
| Earnings Yield | 8.19% |
| FCF Yield | 7.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIO-FD&C has an Altman Z-Score of 25.8 and a Piotroski F-Score of 5.
| Altman Z-Score | 25.8 |
| Piotroski F-Score | 5 |